Qiagen NV | QIA - Selling And Administration Expenses

Stock Price
35.31
Daily Change
0.41 1.17%
Monthly
-13.24%
Yearly
-2.46%
Q2 Forecast
34.40

Qiagen NV reported $153.88M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Akebia Therapeutics USD 23.53M 3.19M Dec/2025
Alaunos Therapeutics USD 585K 84K Sep/2025
argenx SE USD 429.62M 93.32M Dec/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Ionis Pharmaceuticals USD 130M 43.43M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Moderna USD 308M 40M Dec/2025
Organon & Co USD 399M 54M Sep/2025
Qiagen NV USD 153.88M 10.77M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Tectonic Therapeutic USD 3.44M 1.52M Dec/2025
Viatris USD 1.03B 144.1M Dec/2025
Xeris Pharmaceuticals USD 42.64M 3.82M Dec/2025